58 phenotypes from 6 alleles in 10 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Hdac3tm1.1Eno/Hdac3tm1.1Eno Pgrtm2(cre)Lyd/Pgr+ involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6	abnormal decidualization	J:269518
	abnormal embryo attachment	J:269518
	abnormal endometrium morphology	J:269518
	abnormal uterine receptivity	J:269518
	abnormal uterus physiology	J:269518
	endometrium fibrosis	J:269518
	failure of embryo implantation	J:269518
	female infertility	J:269518
	normal homeostasis/metabolism phenotype	J:269518
	increased collagen level	J:269518
	normal reproductive system phenotype	J:269518
Hdac3tm1.1Eno/Hdac3tm1.1Eno Tg(Myh6-cre)2182Mds/? involves: 129S/SvEv * C57BL/6	abnormal cellular respiration	J:144604
	abnormal heart morphology	J:144604
	abnormal heart size	J:144604
	abnormal lipid level	J:144604
	abnormal mitochondrial crista morphology	J:144604
	abnormal myocardial fiber mitochondrial morphology	J:144604
	cardiac hypertrophy	J:144604
	cardiac interstitial fibrosis	J:144604
	normal cardiovascular system phenotype	J:144604
	decreased ventricle muscle contractility	J:144604
	dilated heart left ventricle	J:144604
	increased cardiac muscle triglyceride level	J:144604
	increased heart weight	J:144604
	premature death	J:144604
Hdac3tm1.1Laz/Hdac3tm1.1Laz C57BL/6-Hdac3tm1.1Laz	enhanced long-term object recognition memory	J:168224
Hdac3tm1.1Laz/Hdac3tm1.1Laz involves: C57BL/6	hepatic steatosis	J:206152
Hdac3tm1.1Laz/Hdac3tm1.1Laz Tg(Adipoq-cre)1Evdr/0 involves: C57BL/6 * FVB	normal mortality/aging	J:199860
Hdac3tm1.1Laz/Hdac3tm1.1Laz Tg(Fabp4-cre)1Rev/0 involves: C57BL/6	cachexia	J:199860
	postnatal lethality, incomplete penetrance	J:199860
	premature death	J:199860
Hdac3tm1.1Laz/Hdac3tm1.1Laz Tg(Retn-cre)1Laz/0 involves: C57BL/6	no abnormal phenotype detected	J:199860
Hdac3tm1.1Swh/Hdac3tm1.1Swh involves: 129S6/SvEvTac * FVB/N	embryonic lethality, complete penetrance	J:134665
Hdac3tm1.2Eno/Hdac3tm1.2Eno involves: 129S/SvEv * C57BL/6	abnormal gastrulation	J:144604
	embryonic lethality, complete penetrance	J:144604
Hdac3tm1a(EUCOMM)Wtsi/Hdac3tm1a(EUCOMM)Wtsi B6Brd;B6Dnk;B6N-Tyrc-Brd Hdac3tm1a(EUCOMM)Wtsi/Wtsi	preweaning lethality, complete penetrance	J:211773
Hdac3tm1Swh/Hdac3tm1.1Swh involves: 129S6/SvEvTac * FVB/N	abnormal cell cycle	J:134665
	abnormal cell death	J:134665
	abnormal cell physiology	J:134665
	decreased cell proliferation	J:134665
Hdac3tm1Swh/Hdac3tm1.1Swh Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ involves: 129S6/SvEvTac * C57BL/6 * DBA	abnormal glucose homeostasis	J:134288
	abnormal hepatocyte morphology	J:134288
	decreased body size	J:134288
	decreased circulating glucagon level	J:134288
	decreased circulating insulin level	J:134288
	decreased liver glycogen level	J:134288
	decreased total body fat amount	J:134288
	enlarged liver	J:134288
	hepatic steatosis	J:134288
	hypoglycemia	J:134288
	increased cholesterol level	J:134288
	increased circulating alanine transaminase level	J:134288
	increased circulating cholesterol level	J:134288
	increased circulating LDL cholesterol level	J:134288
	increased circulating triglyceride level	J:134288
	increased hepatocyte proliferation	J:134288
	increased liver triglyceride level	J:134288
	increased liver weight	J:134288
	normal mortality/aging	J:134288
	pale liver	J:134288
Hdac3tm1Swh/Hdac3tm1.1Swh Tg(CAG-cre/Esr1*)5Amc/0 involves: 129S6/SvEvTac * C57BL/6 * CBA * FVB/N	abnormal cell cycle	J:134665
	abnormal DNA repair	J:134665
	increased fibroblast apoptosis	J:134665
Hdac3tm1Swh/Hdac3tm1.1Swh Tg(Mx1-cre)1Cgn/0 involves: 129S6/SvEvTac * C57BL/6 * CBA	abnormal hepatocyte morphology	J:134288
	decreased liver glycogen level	J:134288
	enlarged liver	J:134288
	hepatic steatosis	J:134288
	increased liver weight	J:134288